{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:53:08Z","timestamp":1789260788380,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"am","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.canrad.2023.07.006","type":"journal-article","created":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T08:15:32Z","timestamp":1691309732000},"page":"666-675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Limited applicability and implementation of the international oncology treatments guidelines in low- and middle-income countries, an example from the Mediterranean area borders"],"prefix":"10.1016","volume":"27","author":[{"given":"Y.","family":"Belkacemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-C.","family":"Biston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Benchekroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Benider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Chargari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Debbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"El Kacimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Flandin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Lalya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Samlali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sellal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Supiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2023.07.006_bib0265","series-title":"Clinical Practice Guidelines: Directions for a New Program","article-title":"Institute of Medicine","author":"Committee to Advise the Public Health Service on Clinical Practice Guidelines","year":"1990"},{"key":"10.1016\/j.canrad.2023.07.006_bib0270","first-page":"10S13","article-title":"Evidence based medicine. The facts in the South countries","volume":"23","author":"Fissah","year":"2006","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.canrad.2023.07.006_bib0275","series-title":"Report on the third intercountry meeting on cancer control and prevention, Cairo, Egypt","year":"2001"},{"key":"10.1016\/j.canrad.2023.07.006_bib0280","unstructured":"Adib SM. Lebanon national cancer registry. www.emro.who.int\/ncd\/publications\/NCR-LEB-02."},{"key":"10.1016\/j.canrad.2023.07.006_bib0285","unstructured":"Al-Kayed S. Jordan national cancer registry. www.mecc.cancer.gov\/publications\/epidem.htlm."},{"key":"10.1016\/j.canrad.2023.07.006_bib0290","series-title":"Registres des tumeurs d\u2019Alger","author":"Hamouda","year":"2003"},{"key":"10.1016\/j.canrad.2023.07.006_bib0295","series-title":"Cancer in Africa: epidemiology and prevention. IARC Scientific publications no. 153","author":"Parkin","year":"2003"},{"key":"10.1016\/j.canrad.2023.07.006_bib0300","first-page":"603","article-title":"Epidemiological descriptive approach of cancer in Morocco through the activity of the national institute of oncology 1986\u20131987","volume":"78","author":"Chaouki","year":"1991","journal-title":"Bull Cancer"},{"key":"10.1016\/j.canrad.2023.07.006_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2010.03.007","article-title":"Guidelines, minimal requirements and standard of cancer care around the Mediterranean area: report from the collaborative Arome (Association of Radiotherapy and Oncology of the Mediterranean Area) working parties","volume":"78","author":"Arome","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.canrad.2023.07.006_bib0310","first-page":"2180","article-title":"AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (Arome-Paris) and European School of Oncology (ESO - Milan)","volume":"24","author":"Todorovic","year":"2019","journal-title":"J BUON"},{"key":"10.1016\/j.canrad.2023.07.006_bib0315","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","article-title":"Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative","volume":"11","author":"Singh","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.canrad.2023.07.006_bib0320","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.canrad.2023.07.006_bib0325","unstructured":"National estimates of cancer incidence and mortality in metropolitan France between 1990 and 2018. Study from cancer registers of the Francim network. Volume 1 - Solid Tumors."},{"key":"10.1016\/j.canrad.2023.07.006_bib0330","unstructured":"Registre des cancers de la r\u00e9gion du grand Casablanca\u00a0: rapport d\u2019incidence 2013\/2017. https:\/\/www.contrelecancer.ma\/site_media\/uploaded_files\/Registre_des_Cancers_de_la_Region_du_Grand_Casablanca_2013-2017.pdf."},{"key":"10.1016\/j.canrad.2023.07.006_bib0335","doi-asserted-by":"crossref","first-page":"109589","DOI":"10.1016\/j.radonc.2023.109589","article-title":"ESGO\/ESTRO quality indicators for radiation therapy of cervical cancer","volume":"183","author":"Chargari","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.07.006_bib0340","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/ijgc-2022-004180","article-title":"ESGO\/ESTRO quality indicators for radiation therapy of cervical cancer","volume":"33","author":"Chargari","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2023.07.006_bib0345","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5114\/jcb.2022.116414","article-title":"Brachytherapy infrastructure in sub-Saharan Africa and quest for cervical cancer elimination","volume":"14","author":"Tumba","year":"2022","journal-title":"J Contemp Brachyther"},{"key":"10.1016\/j.canrad.2023.07.006_bib0350","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.radonc.2021.05.010","article-title":"IBS-GEC ESTRO-ABS recommendations for CT based contouring in image guided adaptive brachytherapy for cervical cancer","volume":"160","author":"Mahantshetty","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.07.006_bib0355","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygyno.2021.10.073","article-title":"Increasing global accessibility to high-level treatments for cervical cancers","volume":"164","author":"Chargari","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.07.006_bib0360","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharygeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2023.07.006_bib0365","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40880-016-0103-5","article-title":"A new prognostic histopathologic classification of nasopharyngeal carcinoma","volume":"35","author":"Wang","year":"2016","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.canrad.2023.07.006_bib0370","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1701717","article-title":"Analysis of plasma Epstein-Barr Virus DNA to screen for nasopharyngeal cancer","volume":"377","author":"Chan","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2023.07.006_bib0375","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/cac2.12218","article-title":"The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma","volume":"41","author":"Tan","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.canrad.2023.07.006_bib0380","doi-asserted-by":"crossref","first-page":"E2130","DOI":"10.1002\/hed.23977","article-title":"Evidence on effectiveness of intensity-modulated radiotherapy versus 2-dimensional radiotherapy in the treatment of nasopharyngeal carcinoma: meta-analysis and a systematic review of the literature","volume":"38","author":"Co","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2023.07.006_bib0385","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.meddos.2021.07.002","article-title":"Dosimetric comparison of intensity modulated radiotherapy and intensity modulated proton therapy in the treatment of recurrent nasopharyngeal carcinoma","volume":"47","author":"Hung","year":"2022","journal-title":"Med Dosim"},{"key":"10.1016\/j.canrad.2023.07.006_bib0390","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.canrad.2023.07.006_bib0395","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1470-2045(13)70048-2","article-title":"Planning cancer control in Latin America and the Caribbean","volume":"14","author":"Goss","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2023.07.006_bib0400","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1002\/cncr.29331","article-title":"Health system delay and its effect on clinical stage of breast cancer: multicenter study","volume":"121","author":"Unger-Salda\u00f1a","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2023.07.006_bib0405","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.clon.2014.10.006","article-title":"Need for radiotherapy in low and middle income countries\u2013the silent crisis continues","volume":"27","author":"Zubizarreta","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.canrad.2023.07.006_bib0410","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2023.07.006_bib0415","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2023.07.006_bib0420","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijrobp.2010.04.042","article-title":"Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline","volume":"81","author":"Smith","year":"2011","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.07.006_bib0425","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.breast.2010.03.029","article-title":"Fewer fractions of adjuvant external beam radiotherapy for early breast cancer are safe and effective and can now be the standard of care. Why the UK's NICE accepts fewer fractions as the standard of care for adjuvant radiotherapy in early breast cancer","volume":"19","author":"Harnett","year":"2010","journal-title":"Breast"},{"key":"10.1016\/j.canrad.2023.07.006_bib0430","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1200\/JCO.19.02750","article-title":"Ten-year results of FAST: a randomized controlled trial of 5-fraction whole-breast radiotherapy for early breast cancer","volume":"38","author":"Brunt","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.07.006_bib0435","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue efects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2023.07.006_bib0440","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ijrobp.2016.11.010","article-title":"Hypofractionated Regional Nodal Irradiation for Women With Node-Positive Breast Cancer","volume":"97","author":"Bellefqih","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.07.006_bib0445","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.radonc.2022.07.003","article-title":"HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results - interim analysis","volume":"174","author":"Chakraborty","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.07.006_bib0450","doi-asserted-by":"crossref","first-page":"e2200127","DOI":"10.1200\/GO.22.00127","article-title":"Hypofractionation in Breast Cancer Radiotherapy Across World Bank Income Groups: results of an International Survey","volume":"9","author":"Mushonga","year":"2023","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.canrad.2023.07.006_bib0455","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1200\/JGO.19.00261","article-title":"Can the adoption of hypofractionation guidelines expand global radiotherapy access? An analysis for breast and prostate radiotherapy","volume":"6","author":"Irabor","year":"2020","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.canrad.2023.07.006_bib0460","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ijrobp.2022.11.032","article-title":"In regard to Goldberg et al","volume":"115","author":"Morgan","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.07.006_bib0465","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(13)61950-9","article-title":"Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial","volume":"383","author":"Vaidya","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2023.07.006_bib0470","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1470-2045(13)70497-2","article-title":"Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial","volume":"14","author":"Veronesi","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2023.07.006_bib0475","doi-asserted-by":"crossref","first-page":"e2100376","DOI":"10.1200\/GO.21.00376","article-title":"Modern radiotherapy technology: obstacles and opportunities to access in low- and middle-income countries","volume":"8","author":"Maitre","year":"2022","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.canrad.2023.07.006_bib0480","series-title":"R\u00e9sultats de l\u2019observatoire national de la Radioth\u00e9rapie","author":"Institut national du cancer","year":"2022"},{"key":"10.1016\/j.canrad.2023.07.006_bib0485","first-page":"2","article-title":"Prescribing, recording and reporting of stereotactic treatments with small photon beams. 2017; ICRU report 91","volume":"14","author":"International Commission on Radiation Units and Measurements","year":"2014","journal-title":"J ICRU"},{"key":"10.1016\/j.canrad.2023.07.006_bib0490","series-title":"Stereotactic body radiation therapy: the report of the AAPM Task Group 101. 2011; AAPM report 101","author":"American Association of Physicists in Medicine","year":"2011"},{"key":"10.1016\/j.canrad.2023.07.006_bib0495","series-title":"Qualit\u00e9 et s\u00e9curit\u00e9 des traitements de radiochirurgie et de radioth\u00e9rapie st\u00e9r\u00e9otaxique. Rapport SFPM No\u00a035","author":"Soci\u00e9t\u00e9 fran\u00e7aise de physique m\u00e9dicale","year":"2018"},{"key":"10.1016\/j.canrad.2023.07.006_bib0500","series-title":"Dosimetry of Small Static Fields Used in External Beam Radiotherapy: An IAEA-AAPM International Code of Practice for Reference and Relative Dose Determination","author":"International Atomic Energy Agency, American Association of Physicists in Medicine","year":"2017"},{"key":"10.1016\/j.canrad.2023.07.006_bib0505","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00066-018-1416-x","article-title":"ICRU report\u00a091 on prescribing, recording, and reporting of stereotactic treatments with small photon beams: Statement from the DEGRO\/DGMP working group stereotactic radiotherapy and radiosurgery","volume":"195","author":"Wilke","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2023.07.006_bib0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5603\/RPOR.a2021.0129","article-title":"Special stereotactic radiotherapy techniques: procedures and equipment for treatment simulation and dose delivery","volume":"27","author":"Paoletti","year":"2022","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.canrad.2023.07.006_bib0515","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.radonc.2017.05.012","article-title":"ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer","volume":"124","author":"Guckenberger","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.07.006_bib0520","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.ijrobp.2011.01.052","article-title":"Setup accuracy of the Novalis ExacTrac 6DOF system for frameless radiosurgery","volume":"82","author":"Gevaert","year":"2012","journal-title":"Int J Radiat Oncol Biol Phy"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321823001476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321823001476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:38:23Z","timestamp":1761136703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321823001476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":52,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1278321823001476"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2023.07.006","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limited applicability and implementation of the international oncology treatments guidelines in low- and middle-income countries, an example from the Mediterranean area borders","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2023.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}